Metraipolis › archive › dc_9cfcd2b9ff17
Emicizumab prophylaxis in a preterm infant with severe hemophilia A: a case report on the feasibility of early use — Europe PMC PMID:41953709
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41953709
- DOI
- 10.1016/j.rpth.2026.103401
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T12:38:46.677Z
- SHA-256 of the archived text
bad61d67c40a4d8793274ce743948372d1201ecb888342fcc4c79daa27a2e8fe- Stable URL of this page
https://metraipolis.com/documento/dc_9cfcd2b9ff17
How to cite
Emicizumab prophylaxis in a preterm infant with severe hemophilia A: a case report on the feasibility of early use — Europe PMC PMID:41953709 — Europe PMC (en), https://europepmc.org/article/MED/41953709 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9cfcd2b9ff17 (Metraipolis archive dc_9cfcd2b9ff17, sha256 bad61d67c40a4d8793274ce743948372d1201ecb888342fcc4c79daa27a2e8fe)
BibTeX
@misc{dc9cfcd2b9ff17,
title = {Emicizumab prophylaxis in a preterm infant with severe hemophilia A: a case report on the feasibility of early use — Europe PMC PMID:41953709},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41953709},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9cfcd2b9ff17; sha256 bad61d67c40a4d8793274ce743948372d1201ecb888342fcc4c79daa27a2e8fe},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41953709. Agents can read the archived copy with the MCP tool read_document.